Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs HSBC Holdings plc (HSBC) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
HSBC Holdings plcTrade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs HSBC Holdings plc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.35 (market cap $29.60B), while HSBC Holdings plc trades at $103.85 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 12× Alnylam Pharmaceuticals, Inc.'s market cap, and HSBC Holdings plc pays a 3.63% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.

ALNYHSBC
Market Cap
$29.60B$353.82B
Sector
HealthTechnology
52-Week High
$491.22$107.86
52-Week Low
$205.48$63.84
Enterprise Value
$27.56B
Dividend Yield
3.63%

Returns comparison

Trailing returns across standard periods

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC